Vertebrate immunity to infection enlists a new family of 47 kDa immunity-related GTPases (IRGs). One IRG in particular -Irgm1 -is essential for macrophage host defense against phagosomal pathogens including Mycobacterium tuberculosis (Mtb). Here we show Irgm1 targets the mycobacterial phagosome (PG) via lipid-mediated interactions with phosphoinositide-3,4-bisphosphate (PtdIns[3,4]P 2 ) and PtdIns(3,4,5)P 3 . An isolated Irgm1 amphipathic helix conferred lipid binding in vitro and in vivo. Mutations in this region blocked PG recruitment and failed to complement the antimicrobial defect in Irgm1 -/-macrophages. PtdIns(3,4,5)P 3 removal or class I phosphoinositide-3-OH kinase (PI(3)K) inhibition mimicked this effect in wild-type cells. Irgm1-PI(3)K co-operation further facilitated Irgm1 engaging its fusogenic effectors at the site of infection, thereby ensuring pathogen-directed responses during innate immunity.
INTRODUCTION
Many of the world's most successful intracellular pathogens reside within host membranebound phagosomes (PGs) that provide nutrient access to the recycling endocytic network and shelter from the secreted immune arsenal of antibody and complement. Virulent mycobacteria such M. tuberculosis (Mtb), M. bovis and M. avium are classical examples of persistent micro-organisms that in resting macrophages prevent fusion of their PG niche with lysosomes and autophagolysosomes as a strategy for intracellular survival 1,2. To combat this strategy, vertebrates have evolved innate immune defense mechanisms that facilitate delivery of internalized mycobacteria to acidified secondary lysosomes and intermediates of the autophagic pathway for microbial killing 3-6. How such delivery occurs remains poorly understood but it can be initiated by host cell activation with the T helper type 1 (T H 1) cytokine interferon-γ (IFN-γ), or via Toll-like receptor-4 (TLR4) signaling though the adaptor TRIF 3-6.
The IFN-γ-and lipopolysaccharide (LPS)-responsive GTPase, Irgm1 (also called LRG-47), promotes maturation and acidification of mycobacterial PGs as part of the microbicidal response of Mtb-infected macrophages 3-5. The importance of Irgm1 for control of tuberculosis (TB) is evident in both Irgm1 -/ -macrophages and Irgm1 -/ -mice, with the latter proving profoundly susceptible to Mtb administered by the natural aerogenic route 3,7. Loss of Irgm1 in macrophages yielded specific defects in PG trafficking along the endolysosomal pathway and did not affect other IFN-γ-induced macrophage effector mechanisms such as those involving nitric oxide synthase 2 (Nos2/iNos), phagocyte oxidase (phox) and Slc11a/ Nramp1 (natural resistance associated macrophage protein-1) 3, [8] [9] [10] . Subsequent studies confirmed that Irgm1 and its human ortholog, IRGM, facilitates cell-autonomous resistance to mycobacteria in response to IFN-γ stimulation, TLR4 engagement or cell starvation in murine macrophages and human mononuclear cells 4-6. Irgm1 belongs to a unique class of IFN-γ-inducible 47-48kDa GTPases (p47 IRGs) -comprising 18-23 genes in mice11,12 -that confer innate immunity to compartmentalized intracellular pathogens13,14. These compartments include bacterial PGs, apicomplexan parasitophorous vacuoles and chamydial inclusion bodies. An emerging paradigm therefore posits the IRGs exerting some of their antimicrobial effects by remodeling the pathogencontaining niche or directing vesicular membrane traffic to and from that compartment 12-14. To date, Irgm1 exhibits the most broadly potent resistance profile of all IRGs tested, being obligate for innate defense against mycobacteria, salmonella, listeria, chlamydia, leishmania, toxoplasma and trypanosomes [12] [13] [14] . Surprisingly, however, little is known about the molecular basis of how IFN-γ-inducible Irgm1 engages these vacuolar pathogens within infected cells.
Here, we found that Irgm1 uses selective protein-lipid interactions on the nascent PG membrane to co-ordinate its activity for immunity to mycobacterial infection. A protein-gel overlay screen across 33 lipid species uncovered 3 moieties bound by Irgm1: PtdIns[3,4]P 2 , PtdIns(3,4,5)P 3 and diphosphatidylglycerol (cardiolipin). In silico modeling retrieved a Cterminal lipid binding site that conferred pathogen vacuole attachment; mutations in this region ablated Irgm1 targeting and diminished phagolysosomal fusion. Removal of PtdIns(3,4,5)P 3 on the PG membrane or inhibition of endogenous class I PI(3)Ks and SH2 (Src homology 2)-containing inositol phosphatase-1 (SHIP1; Inpp5d), which are the enzymes responsible for lipid synthesis, also inhibited Irgm1 recruitment to PGs. Irgm1 associated with distinct class I PI(3)K isoforms and enhanced lipid kinase activity; this heightened PI(3)K activity in turn accelerated Irgm1 GTP hydrolysis to promote Irgm1 binding to its fusogenic soluble N-ethylmaleimidesensitive factor (NSF) attachment protein [SNAP] receptor (SNARE) effectors at the site of infection. Thus Irgm1 and class I PI(3)Ks comprise a novel signaling platform for orchestrating early PG events needed for subsequent phagolysosomal transfer. These findings yield the first insight into how p47 IRGs are deployed through direct membrane lipid interactions to combat vacuolar pathogens12-14.
RESULTS

Irgm1 trafficking to PG membranes
Irgm1 residence and its trafficking dynamics upon mycobacterial infection were initially characterized via live or fixed cell imaging together with transmission electron microscopy (EM) of immuno-labeled cryosections to delineate membrane structures. Native Irgm1 resided on cis-medial (GM130) and small < 50nm post-Golgi vesicles lacking early endosomal autoantigen-1 (EEA-1) in IFN-γ-activated primary mouse bone-marrow derived (BMMs) and RAW264.7 macrophages (Fig. 1a-c) . Identical localization was seen in unactivated cells expressing Irgm1 variants tagged with C-or N-terminal enhanced green (EGFP-), yellow (EYFP-), cyan (CFP-) or red fluorescent proteins (RFP-) or tetracysteine (for examples, see Supplementary Fig. 1 online) . Endogenous Irgm1 resided on the cytosolic face of Golgi cisternae like other abluminal proteins that also lack a C-terminal Yxx□ motif 15 needed for internal residence ( Supplementary Fig. 2 
online).
Subsequent infection of IFN-γ-activated macrophages with M. tuberculosis variant bovis BCG led to rapid Irgm1 relocation from the Golgi to mycobacterial PG (MPG) (Fig. 1b) . Endogenous Irgm1 often journeyed great distances -up to 15-30μm -along extended pseudopods to the nascent phagocytic cup enveloping M. bovis BCG (Fig. 1b) . Irgm1 targeting was observed irrespective of whether mycobacteria expressed EGFP, were Cy5-labeled, or were stained via pan-Mtb complex antibody (Ab) or TO-PRO-3 bacterial DNA (Fig. 1b-d) . Likewise, fluorescently-tagged Irgm1 variants co-localized regardless of how mycobacteria were detected (Fig. 1d) . Both bi-directional controls ruled out nonspecific Ab cross-reactivity and validated the reagents used in this study.
Within 3 h of infection, ~20% of MPGs had recruited Irgm1 and this approached 45% after 6 h, by which stage the pathogen vacuole was often completely coated with the GTPase (Fig. 1c; see inset) . After 12 h post-infection (p.i.), ~60% of MPGs were Irgm1 + (Fig. 1c) . Time-dependent MPG targeting in part reflects accumulated uptake since phagocytosis of M. bovis BCG is asynchronous unless first pre-bound at 4°C-16°C to prevent internalization 3. Under the latter circumstances, MPGs became Irgm1 + much earlier (eg. 60-80% within 6 h; data not shown). Live imaging confirmed that Irgm1 could in fact rapidly translocate to sites of mycobacterial uptake viewed every 8 sec over a 20-frame period ( Fig. 1d ; see Supplementary Information, Movie 1). Translocation appeared specific, as it occurred at sites of M. bovis BCG internalization and not randomly to pseudopod extensions or beneath the plasmalemma elsewhere in the cell. Irgm1 remained PG-associated for at least 6 h p.i. during fusion with (auto)lysosomes visualized with 15nm BSA-gold preloaded during an overnight chase3 (Fig. 1e) . Thus Irgm1 partitions between organellar membranes in both uninfected and infected macrophages, residing on Golgi cisternae before prompt deployment to sites of bacterial engulfment 16.
Irgm1 binds PtdIns(3,4)P 2 , PtdIns(3,4,5)P 3 and diphosphatidylglycerol
Biochemical fractionation of IFN-γ-activated macrophages substantiated the conclusion that endogenous Irgm1 was largely membrane-associated; ~89% of Irgm1 was present in the detergent-soluble, non-nuclear pellet (Fig. 2a) . Other p47 IRG family members including Irgm2 (GTPI; 72%), Irgm3 (IGTP; 88%), Irga6 (IIGP1; 83%) were also membrane-bound, although to a lesser extent than Irgm1 (Fig. 2a) .
To identify what membrane lipids Irgm1 interacts with, we screened 33 bioactive species via protein-gel overlay using catalytically-active recombinant Irgm1 fused to glutathione Stransferase (rGST-Irgm1). Three moieties strongly interacted with Irgm1: PtdIns(3,4)P 2 , PtdIns(3,4,5)P 3 and diphosphatidylglycerol (3-bis-sn(3'-phosphatidyl)-sn-glycerol; cardiolipin) (Fig. 2b) . A fourth lipid, phosphatic acid, weakly associated with rGST-Irgm1. Of the remaining p47 IRGs screened, only rGST-Irgm3 displayed conspicuous lipid binding activity that was again weaker than rGST-Irgm1 (Fig. 2b) . GST alone or rGST-Irgm1 preincubated with 15-fold molar excess (1.5nmol) of each lipid substrate was not detected, confirming the specificity of the interaction (Fig. 2c) . Dose-dependent rGST-Irgm1 binding of PtdIns(3,4)P 2 and PtdIns(3,4,5)P 3 among 8 different phosphoinositides was also noted over 1.6-100 pmol range (Fig. 2d ). That these interactions could occur within the context of a three-dimensional lipid bilayer was seen using PtdIns(3,4)P 2 -or PtdIns(3,4,5)P 3 -containing liposomes (Fig. 2e ).
Irgm1 C-terminal αK helix confers lipid-binding
We next sought to identify the Irgm1 region(s) involved in binding these lipid species. Lack of transmembrane or post-translational lipid-binding motifs led us to consider an in silico approach incorporating secondary structure predictions. Here, low-stringency peptidic blast searches were engrafted onto a computed 3D Irgm1 model based on dimeric Irgb6/IIGP1 (PDB code 1TQ2:2), crystallized in the presence of phosphoaminophosphonic acidguanylate ester17 (Fig. 3a) . This analysis identified polybasic, hydrophobic and amphipathic stretches exposed for membrane targeting. A C-terminal amphipathic alpha helix ([αK] Irgm1 350-374, isoelectric point [pI] 9.0) structurally amenable to lipid membrane interactions was enriched in basic (6/25) plus hydrophobic (14/25) residues (Fig. 3a) . Three adjacent helices ([αỊ,αJ] Irgm1 330-349 , [αL] Irgm1 386-409 also contained basic (αỊ,αJ -5/20; αL -3/24) and hydrophobic (αỊ,αJ -6/20; αL -11/24) residues but had isoelectric points well below that of the overall molecule (6.4 and 6.3 versus 8.3). Modeling also showed that the αL domain packs against the αF helix in an antiparallel orientation, making it unlikely to be membrane accessible.
Direct gel overlay and liposome sedimentation assays confirmed the importance of Irgm1 αK region for lipid binding. Here, the 25 amino-acid rGST-Irgm1 350-374 helix recapitulated the lipid interaction profile of full-length rGST-Irgm1 in dose-dependent fashion (Fig. 3b,c) . Mutations that destroyed amphipathicity (rGST-Irgm1(F362E,R367E): Fig. 3b, 3d ) or replaced specific positively-charged and hydrophobic residues with uncharged, nonhydrophobic alanine (rGST-Irgm1(K350,R352,M354A,C356)) abolished lipid binding (Fig.  3b, 3d ). The N-terminal G-domain plus αẸ,αF helices (rGST-GD 75-289 ) did not recapitulate the lipid binding profile of full-length Irgm1, reinforcing that much of the lipid-binding activity resides further downstream in the C-terminal αK domain (Fig. 3d) . Because αK mutants retained GTPase activity, their failure to bind PtdIns(3,4)P 2 , PtdIns(3,4,5)P 3 and diphosphatidylglycerol was not due to gross conformational changes caused by mutagenesis (Fig. 3e) .
At physiological pH, PtdIns(3,4)P 2 , PtdIns(3,4,5)P 3 and diphosphatidylglycerol can carry net negative charges of -2 to -7 from several PO 4 -moieties 18; these likely interact with polycationic side chains (6 arginines, 1 lysine) within the 25 amino acid αK helix of Irgm1. However, mutations interfering with uncharged, hydrophobic amino acids on the amphipathic face (F362E) also compromised lipid interactions. Fig. 3 online). Strong PtdIns(3,4)P 2 and PtdIns(3,4,5)P 3 staining was absent from Golgi stacks; thus the role of these lipids may instead be to target Irgm1 to the PG membrane during infection.
Irgm1 targeting to MPGs promotes immunity
First we determined if PtdIns(3,4)P 2 and PtdIns(3,4,5)P 3 are generated at sites where Irgm1 accumulates. EYFP fused to the pleckstrin homology domains (PH) of tandem-PH domain containing protein-1 (EYFP-PH-TAPP1; 80nM K d for PtdIns(3,4)P 2 )19 or of general receptor for phosphoinosides protein-1 (EYFP-PH-GRP1; 170nM K d for PtdIns (3, 4, 5) 3 )19 were nucleoporated into IFN-γ-activated macrophages that were subsequently infected with Cy5-labelled M. bovis BCG. Live imaging often revealed bursts of PI(3,4,5)P 3 synthesis that coincided with rapid recruitment (~10-20 s later) of CFP-Irgm1 to sites of bacterial internalization (Fig. 4a ). CFP-Irgm1 was also recruited to PtdIns(3,4)P 2 -enriched phagocytic cups but here the appearance was transient and occurred at slightly later times (2-5 minutes p.i., Supplementary Fig. 4 online).
Thus a switch from PM-derived PtdIns(3,4,5)P 3 to PG-derived PtdIns(3,4)P 2 may accompany vacuole maturation, eventually leading to PI(3)P generation alongside that synthesized de novo by the class III PI(3)K Vps34p 20. Indeed, using the PX domain of NADPH phox40 subunit fused to EYFP (EYFP-p40-PX) as a PtdIns(3)P-specific sensor 20, M. bovis PGs became positive for this probe ~5-15 minutes after Irgm1 was recruited ( Supplementary Fig. 4 online). Diphosphatidylglycerol (cardiolipin) was also detected on MPGs at later times (~10-30 min p.i. Supplementary Fig. 4 online) but, unlike PtdIns(3)P, its presence partly depended on bacterial viability (data not shown). Mtb secretes lysocardiolipin that is exported from PGs following cleavage by host lysosomal phospholipase A2 21; thus some PG lipid detected via anti-cardiolipin is probably pathogenrather than host-derived. Delayed appearance of diphosphatidylglycerol on PG membranes also suggests that the main function of this lipid may be to help retain, rather than recruit, Irgm1.
What regions of Irgm1 are needed for its recruitment to MPGs? EGFP-αK but not the neighboring EGFP-αI,αJ region was sufficient to target MPGs (Fig. 4b,c) . Some 30% of PGs became αK-positive within 3-12 min of bacterial uptake. Recruitment was lost, however, when PtdIns-binding mutations were introduced into the αK helix (EGFP-αK(F362E,R367E)) or full-length protein (EGFP-Irgm1(F362E,R367E)) or when the Cterminus containing αK was removed (EGFP-GD 75-292 ) (Fig. 4b,c) . Importantly, nucleoporation of EGFP-Irgm1 but not EGFP-Irgm1(F362E,R367E) into primary IFN-γ-activated Irgm1 -/ -BMMs rescued MPG transfer to proteolytically-active lysosomes as measured by dequenching of difluoro-4-bora-3α,4α-diaza-s-indacene conjugated to bovine serum albumin (DQ Red BSA) ( Fig. 4d ; Supplementary Fig. 5 online) . Thus an intact αK domain is necessary and largely sufficient to target Irgm1 via lipid-protein interactions to MPGs where it functions to promote antimicrobial activity.
Class I PI(3)K and SHIP1-derived PtdIns help recruit Irgm1
Irgm1 First, local PtdIns(3,4,5)P 3 was removed by targeting a yeast PtdIns(5)P-specific phosphatase, Inp54p 25, to MPGs. Here, Inp54p was fused to FKB that upon rapamycin (Rap) treatment dimerizes with FKBP already tethered to PGs via a Lyn kinase PM motif. This strategy enabled Inp54p to deplete PtdIns(4,5)P 2 and PtdIns(3,4,5)P 3 specifically on early PG membranes, ruling out potential interference with these lipids in Irgm1 exit from the Golgi. Simultaneous PI(3)K inhibition by wortmannin was also used to ensure any residual PtdIns(4,5)P 2 is not converted to PtdIns(3,4,5)P 3 . CFP-Inp54p-FRB bound FKBP on MPG membranes within 4-12 minutes of Rap exposure (Fig. 5a ). Dimerized CFPInp54p-FRB markedly inhibited Irgm1 trafficking to the MPG by 55.4% in the absence of wortmannin, confirming that the site of PtdIns(3,4,5)P 3 synthesis is a important spatial cue directing Irgm1 recruitment (Fig. 5a ). Neither Rap alone nor Inp54p minus Rap affected Irgm1 translocation (Fig. 5a ). Wortmannin alone inhibited translocation by 67.2%, as scored by "inside-out" staining to mitigate any effects on mycobacterial uptake 26 (see Supplementary Fig. 6 online). Thus other 3'-phosphate-containing lipid species such as PtdIns(3,4)P 2 are needed along with PtdIns(3,4,5)P 3 to recruit Irgm1 to MPGs (Fig. 5a ). That both lipids are important is underscored by the observation that combined Rap-Inp54p plus wortmannin treatment was the most effective intervention (75.4% inhibition; Fig. 5a ).
Next, we determined which class I PI(3)K isoforms generate the Irgm1-binding lipids needed for MPG recruitment. This question became relevant since wortmannin affects all PI(3)K classes (IC 50 ~3-5nM) as well as mTOR, DNA-PK, ATM and class II PIPkins α and β 22,27. We probed the requirement for ~110kDa catalytic (Class IA: Pik3ca, Pik3cb, Pik3cd; Class IB: Pik3cg) and 85kDa regulatory (Pik3r1-r2) subunits through isoformspecific drug inhibition or siRNA treatment; we also used siRNAs to silence SHIP1 (Fig.  5b) Fig. 7 online) . siRNA treatment showed that both Pik3r1-r2 85kDa subunits (and possibly their 55kDa splice variants 22, Fig. 5b ) along with SHIP1 were also needed for Irgm1 relocation (48.2-62.9% inhibition; Fig. 5c,d ). Thus Pik3ca-Pik3r1-r2 heterodimers appear to be the major class I PI(3)K isoforms acting with SHIP1 to furnish PtdIns(3,4)P 2 and PtdIns(3,4,5)P 3 at sites of Irgm1 targeting on the nascent PG membrane.
Interplay between Irgm1 and class I PI(3)K
Scanning meta-confocal microscopy found Irgm1, Pik3ca, Pik3r1-r2 and SHIP1 together on phagocytic cups engulfing mycobacteria (Fig. 5e) . Moreover, Irgm1 physically interacted with Pik3ca and with both Pik3r1and Pik3r2 subunits, strengthening the idea that PtdIns synthesis and Irgm1 recruitment are spatially linked. Flag-Pik3ca bound EGFP-Irgm1 (Fig.  6a) as well as known Pik3ca interactors, HA-p21 Ras and its constitutively-active variant, HA-p21 RasQ61L (data not shown) 31. Flag-Pik3ca did not, however, co-immunoprecipitate EGFP alone (Fig. 6a) , EGFP-Pik3cb, EGFP-Pik3cg, or SHIP1, nor was it captured by an irrelevant isotype-matched IgG (data not shown). Likewise, Myc-Irgm1 bound EGFP-Pik3r1 and EGFP-Pik3r2, albeit consistently weaker than EGFP-Pikca (Fig. 6b) . A similar outcome was seen in direct GST pulldown assays (Fig. 6c,d ). Irgm1-Pik3ca interactions relied on regions outside of the αK helical region; EGFP-Irgm1, EGFP-Irgm1(F362E,R367E) and EGFP-GD 75-292 all bound Flag-Pik3ca whereas EGFP-αK did not (Fig. 6e) . Thus lipid-and PI(3)K-binding interfaces of Irgm1 appear to be distinct.
What are the biochemical consequences of Irgm1-PI(3)K interactions? rGST-Irgm1 accelerated Pik3ca-Pik3r1 heterodimer-mediated PtdIns(4,5)P 2 phosphorylation to PtdIns(3,4,5)P 2 (Fig. 6f) . This effect was blocked by wortmannin (Fig. 6f) . Two positive controls, HA-p21 Ras and HA-p21 RasQ61L , as well as the GTPase-inactive rGSTIrgm1(S90N) mutant also accelerated PtdIns(4,5)P 2 phosphorylation (Fig. 6f) . Thus Irgm1 functions like p21 Ras to enhance lipid kinase activity although, unlike the latter 31, it does not strictly rely on nucleotide catalysis or G-domain conformation.
PI(3)K likewise regulated Irgm1 catalysis. rPik3r1 increased Irgm1 GTPase activity in single-turnover GAP assays; this effect was abolished by Arg274 mutations within the Pik3r1 Ras binding domain (RBD; rPik3r1(R274A)), a region known to serve as a Rab5GAP 32 (Fig. 6g) . Highly-purified rPik3r1 induced more modest increases in Irgm1 GTPase activity compared with Rab5 (400nM rPik3r1 used per reaction due to limited supply versus 10μM described previously33) (Fig. 6g) . Nonetheless, enhanced activity was still evident.
We also found that PtdIns(3,4)P 2 and PtdIns(3,4,5)P 3 -dependent lipid-binding enhanced Irgm1 catalysis. In these experiments we directly measured GTPase activity of Irgm1 on liposomes incorporating either 5% mol/mol PtdIns(3,4)P 2 or PtdIns(3,4,5)P 3 (Fig. 6h) . Lipidtethered rGST-Irgm1 but not rGST-Irgm1(F362E,R367E) exhibited marked increases in catalysis (2.82-3.62 fold) versus liposome-free (Fig. 3e ) or control PC:PE liposome samples (Fig. 6h,i) . In structural terms, intramolecular inhibition exerted by the αK helix may be relieved after binding lipid bilayers 33; this effect could account for the increased GTPase activity of liposome-bound Irgm1. Likewise, Irgm1(F362E,R367E) exhibited heightened activity versus Irgm1 in the absence of lipid (7.15 ± 0.83 v. 1.42 ± 0.20 nmol GTP hydrolyzed/min/nmol protein) (Fig. 6h,i) , suggesting it may already adopt a conformation analogous to lipid binding. Thus specific PtdIns not only provide spatial cues for MPG recruitment but can act as an allosteric switch 33 for Irgm1 catalysis once the latter is targeted to this environment.
Irgm1-PI(3)K co-operation engages fusogenic effectors
How do enhanced Irgm1 and class I PI(3)K catalytic activities benefit anti-mycobacterial immunity? Accelerated GTP hydrolysis may promote binding of Irgm1 to fusogenic partners that induce MPG maturation. Alternatively, elevated class I PI(3)K synthesis of PtdIns(3,4,5)P 3 and resultant PtdIns(3,4)P formation could help bring Irgm1 effectors in close proximity with the GTPase. Either outcome would reinforce the other.
To test the first possibility, we conducted a yeast-2 hybrid (Y2H) screen to isolate fusogenic partners, as Irgm1 effectors have not been identified. Two membrane trafficking proteinsSnapin (soluble N-ethylmaleimide-sensitive factor (NSF) attachment protein [SNAP]-associated protein) and Tmed10 (transmembrane emp24-like trafficking protein 10) -were retrieved in this screen (Fig. 7a) . Snapin binds to t-SNARE complex proteins on donor membranes and promotes accelerated fusion with cognate v-SNARE-expressing compartments (eg. lysosomes) 34-36. Tmed10, in contrast, assists COPI and COPII transport between the Golgi and ER39. As such we focused on Snapin given its fusogenic function and importance for mycobacterial control (H.P.C, S.T., T.M., J.D.M., manuscript in preparation).
Snapin bound to Irgm1 and a known t-SNARE interactor, Snap23 34, in coimmunoprecipitation ( Fig. 7b ) and GST pulldown (Fig. 7c) assays. Snapin binding was blocked using a non-hydrolyzable Irgm1 substrate, GTP-γ-S, and was increased using GDP plus aluminum fluoride (AIF x ) that allows Irgm1 to adopt the transition state conformer, mimicking structural changes during hydrolysis 33 (Fig. 7C ). Thus heightened GTPase activity brought about by Pik3ca-Pik3r1, PtdIns(3,4,5)P 3 and PtdIns(3,4)P 2 may favor Irgm1 binding its fusogenic effectors. Likewise, protein-gel overlay showed that Snapin specifically interacted with PtdIns(3,4,5)P 3 , PtdIns(3,4)P 2 , PtdIns(3)P and to a lesser extent, PtdIns(4)P (Fig. 7d) . Thus elevated lipid kinase activity could help retain Irgm1 effectors like Snapin on the PG.
Both possibilities were tested by chemical and genetic loss-of-function approaches. First, coimmunoprecipitation of Irgm1 by Snapin was conducted in the presence of 15e, TXG-221, and AS-252424. Inhibition of class I PI(3)K activity severely reduced Irgm1-Snapin interaction (Fig. 7e) . Second, PtdIns-binding mutations greatly diminished the ability of Irgm1 to bind Snapin in untreated cells (Fig. 7f) . Thus lipid-mediated targeting of Irgm1 is critical for this GTPase to engage its effectors, most likely at the site of infection since endogenous Snapin strongly localized to PGs in M. bovis-infected macrophages (Fig. 7g) . Notably, Snapin targeting itself did not require lipid kinase or Irgm1 activity; it still localized to MPGs in primary IFN-γ-activated Irgm1 + / + and Irgm1 -/ -macrophages treated with 15e, TXG-221 and AS-252424 ( Fig. 7g ; Supplementary Fig. 8 online) . Class I PI(3)K products therefore aid recruitment of the GTPase rather than sequestration of the effector. Such a model is consistent with the weak coimmunoprecipitation of Snapin by Irgm1(F362E,R367E) because the latter cannot translocate to PG membranes (Fig. 4b,c) . PI(3)K-mediated MPG targeting of Irgm1 thus promotes access of the GTPase to its fusogenic partners for facilitating SNARE complex assembly. In summary, these findings indicate that PI(3)K-derived PtdIns help integrate recognition and effector events that confer Irgm1-mediated defense against phagosomal pathogens.
DISCUSSION
Here we identified PtdIns(3,4)P 2 and PtdIns(3,4,5)P 3 as important spatial cues for Irgm1 recognition of nascent PG membranes within minutes of bacterial uptake. Once recruited, Irgm1 co-operates with resident class I PI(3)Ks for binding effectors to initiate its antimicrobial activity.
These findings parallel a recent landmark study of the Ras, Rab, Arf and Rho GTPases wherein nearly a third of 125 proteins examined were peripherally targeted via PtdIns(4,5)P 2 and/or PtdIns(3,4,5)P 3 in uninfected fibroblasts 25. As basal concentrations of PtdIns(3,4,5)P 3 are typically low (5μM), either high-affinity PH domains (30- Supporting this conclusion, GTPase-deficient Irgm1(S90N) fails to complement the fusogenic defect in Irgm1 -/ -macrophages (H.P.C, S.T., T.M., J.D.M., manuscript in preparation); this failure is in part due to the fact that GTPase activity is required to assemble SNARE adaptors that preferentially bind the Irgm1 transition-state conformer. Thus Pik3ca-Pik3r1 may help hydrolyze newly-recruited Irgm1 which, in its transition-state, captures fusogenic partners. Such an exchange likely takes place on phagocytic cups since both enzymes localize to these regions and class I PI(3)K inhibitors interfere with Irgm1-Snapin binding. Moreover, GTP hydrolysis only appears effective after Irgm1 is first recruited to Snapin-positive MPGs, as Irgm1(F362E,R367E) failed to rescue the lysosomal targeting defect in IFN-γ-treated Irgm1 -/ -macrophages despite its elevated catalytic activity. Once recruited, Irgm1 probably regulates effectors for the next stage of phagolysosomal transfer in what is largely a Pik3ca-Pik3r1/2-independent manner. This is because PtdIns(3,4,5)P 3 and PtdIns(3,4)P 2 are metabolized soon after PG closure 23,38,40. Such a proposal fits with earlier observations that Pik3r1-r2 -/ -murine embryonic fibroblasts have major deficiencies in PG formation but not maturation 26.
Based on our results, a model emerges in which translocation events could be considered "activating" by helping to bring a structurally-favored Irgm1 in close proximity with binding partners such as GAPs or SNARE components that mediate subsequent fusogenic activity. Indeed, IFN-γ-induced phagolysosomal transfer is essential for mycobacterial killing; genetic lesions that block lysosome delivery (Irgm1 -/ -, Atg5 -/ -) 3,44 or accelerate it (coronin-1 -/ -) 45 inhibit or promote macrophage tuberculocidal activity, respectively. So, too, do drugs that either prevent PG acidification (Bafilomycin A, omeprazole) 3 or relieve PG maturational arrest (H-89, which targets AKT1) 46. Both lines of evidence underscore the importance of non-oxidant defense against mycobacteria and the contribution of IFN-γ-induced Irgm1 to that process. In addition, recent evidence implicates Irgm1 in autophagic regulation of CD4 + lymphocyte survival 47, suggesting this GTPase utilizes common organizing principles to exert specialized membrane regulatory functions during innate as well as acquired immunity. Such widespread cellular involvement may explain why Irgm1 deficiency results in susceptibility to so many diverse phagosomal pathogens 3,7,12-14. Our studies provide the first molecular glimpse of how Irgm1 uses lipid-protein interactions to initiate its antimicrobial activities against a classic membrane-bound organism.
METHODS
Nucleoporated plasmids
We used 16 Irgm1 and 7 class I PI ( Table 1 online.
Cell culture, transfection and mycobacterial infection
Primary BMMs from congenically-matched Irgm1 + / + or Irgm1 -/ -mice maintained under specific-pathogen free conditions (SPF) were differentiated as described 3. All mice were handled according to institutional guidelines for animal care and use. RAW264.7, COS-1, HeLa and HEK cells (ATCC) were cultured in either RPMI or DMEM (containing 10% heat-inactivated FBS, 4mM L-glutamine, 100 U/ml penicillin G, 100μg/ml streptomycin). Cells were nucleoporated (Amaxa) to avoid lipid carrier-based transfection reagents that might interfere with protein trafficking, or viral-mediated gene delivery that might activate control cells. Recombinant mouse IFN-γ (R &D; 100U.ml -1 ) was added 4 h postnucleoporation and M. bovis BCG (MOI, 5:1) 20h later for a 60 min chase period. M. bovis BCG (Phipps strain) or recombinant BCG (Pasteur) harboring an episomal GFP(S65T) bright mutant (rBGP-GFP) 48 were grown in 7H9 broth (GIBCO) plus 10% OADC; the latter strain was kept under 25μg/ml kanamycin selection. Cy5-labelling of BCG was conducted in 0.1M NaCHO 3 buffer, pH 9.3, followed by amino group neutralization and washing with 50mM Tris buffer, pH 8.0. Heat-killed bacteria was confirmed by 7H10 agar plating.
Antibodies
All were rabbit, goat or donkey primary Abs unless otherwise stated: Anti-Irgm1 (A19), anti-Irgm2 (M14), anti-Irgb6 (G20), anti-Pik3r1 (Z8), anti-Pik3r2 (T15) and anti-Inpp5d (P1C1) were from Santa Cruz Biotechnology; anti-Pik3ca (4255), anti-Pik3cg (4252), antiPik3r1/r2 (4292) were from Cell Signaling; anti-Irgm3 (7) and anti-Pik3ca (19) were from BD Biosciences; anti-actin (A2066), anti-GST mAb (G1160) and anti-FLAG M2 (F3165)
were from Sigma. We also used anti-Pik3ca (AP8016, Abgent), anti-EEA-1 (324610, Calbiochem), anti-cardiolipin (human IgG HCL-0100, Immunovision), anti-Mtb complex (B65601B, Biodesign International), anti-Snapin (148002, Synaptic systems); anti-HA (MMS-101R, Covance), anti-GFP (7.1/13.1, Roche), anti-GM130 (G. Warren, Vienna) 49, donkey anti-goat, anti-mouse, and anti-rabbit Ig-Alexa488 or Alexa594 (A1105, A-21203, A21207) and anti-Myc (9E10) (Molecular Probes-Clontech).
4D confocal and cryo-electron microscopy
For live imaging, 2 × 10 5 macrophages were nucleoporated, dispensed onto MatTek glassbottom dishes and activated for 16-24 h with IFN-γ (100U.ml -1 ). rBGP-GFP or Cy5-BCG were pulse-chased for 40-60 min before recording at 37°C under oil (100x objective) on a Zeiss LSM510 confocal microscope in MetaDetector mode. Compressed Z-series were deconvolved using AutoQuant 3D (InVision) or ImageJ (NIH) software to yield 4D data over time. When applied, pseudocoloring used original pinhole, Airy disc and intensity gain settings. Static images were captured on 3% PFA-fixed samples. Cardiolipin was detected via a nonyl acridine orange stain 50. EM cryosections were processed as described 49 and stained with A19 or anti-EGFP followed by either rabbit anti-goat or anti-mouse (Jackson Immunochemicals) and then Protein A-10nm gold. BSA-gold (15nm) tracer was pulsechased into IFN-γ activated macrophage lysosomes overnight and unsonicated BCG (MOI 10:1) added for 60 min at 16°C. Mycobacterial uptake was initiated by shifting to 37°C to allow phagosomal trafficking for 6 h 3.
Recombinant proteins
GST-tagged proteins were expressed in bacteria (E. coli BL21DE3-RIPL), isolated using glutathione Sepharose 4B and desalted using GST-or Sephadex G-25 superfine Hi-Trap (to remove trace MgCl 2 ) via fast protein liquid chromatography (FPLC). These proteins included rGST-Irgm1, rGST-Irgm1(S90N), rGST-Irgm1(F362E,R367E), rGSTIrgm1(K350,R352,M354A,C356A), rGST-αK 350-374 , rGST-GD 75-292 , rGST-Irgm2, rGST-Irgm3, rGST-Irgb6, rGST-Rab5a, rGST-Pik3r1, rGST-Pik3r1(R274A) rGST-Snapin and rGST alone. Soluble Pik3r1, Pik3r1(R274A) and Snapin were generated via Precision protease cleavage (2U/mg protein). His 6 -Snapin (pET-28a, Novagen) was isolated on Ni 2+ columns and subjected to FPLC as above.
Membrane fractionation, protein-lipid gel overlay and liposome assays
Fractionated lysates (Subcellular Proteome Extraction, Calbiochem) were immunoblotted with anti-Irgm1, anti-Irgm2, anti-Irgm3 or anti-Irgb6 before quantitation via densitometry. For protein-gel overlay, nitrocellulose filters harboring biologically-active lipids (Echelon) were blocked with 0.1% OVA in TBST (10mM Tris pH 8.0, 150mM NaCl, 0.1% Tween-20) before adding molar equivalents of each GST-fusion protein (13.7 nmol) plus anti-GST. After washing, filters were incubated with secondary anti-mouse IgG 2a (Jackson Immunochemicals) before detection via ECL Plus kit (Amersham). Liposome binding used 1mM PC:PE:biotin-PE (65%:29%:1% mol:mol) liposomes (Echelon) with 5% PtdIns(3,4,5)P 3 or PtdIns(3,4)P 2 incorporated. GST-fusion proteins were added at 25°C in 50 mM Tris pH 7.5, 150 mM NaCl, 0.05% NP-40 buffer with shaking. Liposome aliquots were removed for immunoblotting the pre-pellet load before centrifugation (20,000 x g, 20 min) and washing cycles. The pellet was then immunoblotted with anti-GST for detection of sedimented rGST-Irgm1 in the post-pellet fraction.
Irgm1 structural modeling
An Irgm1 homology model was generated in Modeller (9v1, 1) using the crystal structure of Iigp1 (Irga6) bound to Mg 2+ and GNP (phosphoaminophosphonic acid guanylate ester; PDB code 1TQ2; 2) with a manually curated sequence alignment based on Probcons and 3DPSSM. The GROMOS96 force-field in SwissPDB Viewer (v3.7; http://www.expasy.org/ spdbv/) was used for energy minimization. Structures were rendered using PyMol (www.pymol.org) 12.
GTPase assays
[ 32 P]GTP hydrolysis by 200nM rGST, rGST-Irgm1, rGST-Irgm1(S90N),rGSTIrgm1(F362E,R367E) in reaction buffer (50mM Pipes (pH 7.0), 5mM MgCl 2 , 10μM GTP, 100nM [ 32 P]GTP)was assayed at 37°C. After charcoal column removal of GDP and GTP, liberated P i was measured via scintillation counter. Heat-inactivated GST-Irgm1 served as a negative control. Where used, 500 μM liposomes were pre-incubated with substrate and enzyme for 10 min before addition of MgCl 2 to initiate the reaction. Single turnover GAP assays were performed using 200nM rGST-Irgm1 or rGST-Rab5a immobilized on glutathione Sepharose 4B beads for pre-binding 500 nM [ 32 P]GTP. Unbound substrate (>99.7% as measured via scintillation counting) was removed by repeated washing and rPik3r1 or rPik3r1(R274A) (400nM) added to bind Irgm1 and Rab5a (positive control) for 10 min before catalysis. rGSTIrgm1 or rGST-Rab5a without Pik3r1 reactions served as controls. Neither rPik3r1 or rPik3r1(R274A) alone displayed [ 32 P]GTP hydrolyzing activity (data not shown).
MPG and PM PtdIns depletion in vivo
Macrophages were nucleoporated with constructs encoding FRB-CFP-Inp54p, Lyn11-FKBP and EYFP-Irgm1, pre-activated with IFN-γ and pulsed for 15 min with 10μM rapamycin in the presence or absence of 500nM wortmannin throughout the assay. Cells synchronouslyinfected with Cy5-BCG were then live-imaged for 3 h. Z-series identified the percentage of uninternalized bacteria; this percentage closely matched the percentage obtained from nonpermeabilized coverslips co-stained with anti-Mtb pAb coupled to Alexa488 to detect external Cy5-BCG ("inside-out" staining, Supplementary Fig. 5 online) . Autophagy was not observed with 10μM rapamycin for 15 min as this drug induces strong autophagic responses only when present at 50-100μM for longer periods (e.g. 2h) in RAW264.7 macrophages 4,5.
Class I PI(3)K gene silencing and pharmacologic inhibition
siRNAs (siGENOME SMARTpools, Dharmacon) were nucleoporated and 4 h later IFN-γ was added for 16-20 h before infection. siRNAs used were Pik3r1 (L-041079-00-0005), Pik3r2 (L-041085-00-0005), SHIP1 (Sc-36491, Santa Cruz), control (ON-TARGET plus Non-targeting). Gene silencing was confirmed by immunoblot. Chemicals were used at 10-500 fold >IC 50 concentrations to ensure inhibition but 4-5 fold < IC 50 of other class I PI(3)K isoforms to retain selectivity (1μM for 15e, μM for TXG-221 and 350nM for AS-252424) 28-30. Such treatment inhibited Flag-Pik3ca-Pik3r1 or Flag-Pik3cb-Pik3r1 activity in an isoform-specific fashion. Drug uptake was enhanced by incubation in serumfree plus phosphate-free media 20 min before M. bovis infection and in complete media thereafter.
Lipid kinase assays
Class I PI(3)K activity was measured via ELISA sandwich assay (K-2600, Echelon) on HEK cells transfected with both heterodimeric subunits, Flag-Pik3ca and Pik3r1-Flag, before capture and washing on 50% Protein G-agarose with TNE (10mM Tris-HCl, pH 7.4, 150 mM NaCl and protease as well as phosphatase inhibitors). PI(3)K reaction buffer supernatants (2.5 mM MgCl 2 , 5 mM Hepes pH 7, 25 μM ATP) containing 500 pmol diC 8 PtdIns(4,5)P 2 with or without rGST-Irgm1 variants (1.6μM) were incubated for 3 h at 25°C, after which PtdIns(3,4,5)P 3 was measured as per the manufacturer's protocol. Transiently-expressed HA-tagged p21 Ras or HA-p21 RasQ61L were immunoprecipitated and TEV-cleaved, with the resulting soluble proteins were added to Pik3ca-Pik3r1 as a positive control. Wortmannin (500nM) or 15e (μM) added 20 min prior to the reaction served as negative controls.
Yeast 2-hybrid screen
Screening was performed using MATCHMAKER GAL4-based twohybrid system III (BD Biosciences, Clontech). pGBKT7-Irgm1 served as bait to screen a hightiter murine embryonic fibroblast (MEF) library expressed in pACT2. pGBKT7-Irgm1 plus the pACT2 library were introduced into Saccharomyces cerevisiae AH109, and bacteria were successively plated for 7 days at 30°C on SD medium lacking histidine, leucine, and tryptophan (SD-HLT) and SD medium lacking adenine, histidine, leucine, and tryptophan (SD-AHLT) in the presence of X-αGal (5-bromo-4-chloro-3-indolyl-αD-galactopyranoside) Positive phenotype ("blue") colonies were isolated, and pACT2 cDNA inserts in these colonies were rescued and confirmed via retransformation. Isolates were then subjected to a third-round stringency screen, after which DNA prepared, sequenced and analyzed by BLAST search. pGBKT7-cI + pACT2-cI containing the bacteriophage lambda cI gene fragment that encodes a repressor protein homodimeric domain served as a positive control.
Co-immunoprecipitation and GST pulldown assays
For co-IP assays, HEK cells expressing either Flag-or Myc-tagged proteins along with the respective EGFP-tagged partner proteins were lysed in RIPA buffer (150mM NaCl, 1% NP-40,0.5% DOC, 0.1% SDS, 50mM Tris pH 8.0, protease inhibitors and phosphatase inhibitors for PI(3)K) and clarified by centrifugation at 4°C. Whole cell lysates (WCL) were pre-cleared with protein A/G Sepharose beads to eliminate nonspecific binding and supernatants were incubated with the respective antibodies; immunoprecipitates were then washed and subjected to immunblot. GST pulldown assays consisted of soluble rGST or rGST-tagged proteins immobilized on glutathione-Sepharose 4B beads that were incubated with pre-cleared WCL containing transiently-expressed Flag-Pik3ca and Pik3r1-Flag. Beads were extensively washed and immunoblotted as described above.
Statistics
Differences between control and experimental groups were analyzed via single factor analysis of variance (ANOVA) or Student's t-test. P values less than the threshold statistic is shown. 
